论文部分内容阅读
目的:探讨连续性肾脏替代治疗(CRRT)在主动脉球囊反搏(IABP)抢救心源性休克并急性肾功能衰竭(ARF)的效果。方法:回顾性分析我院1998至2009年在积极药物治疗基础上使用IABP联合CRRT(CRRT组)31例或床边血液透析治疗(HD)(HD组)21例抢救心源性休克并ARF患者的临床资料,观察两组疗效及并发症。结果:CRRT组抢救成功12例,死亡率为61.3%;HD组抢救成功3例,死亡率90.5%(P<0.05)。两组在出血、下肢缺血等并发症无显著差异。结论:在IABP抢救心源性休克并ARF时,CRRT是首选透析方式。
Objective: To investigate the effect of continuous renal replacement therapy (CRRT) on rescuing cardiogenic shock and acute renal failure (ARF) in aortic balloon pump countercurrent (IABP). Methods: A retrospective analysis of our hospital from 1998 to 2009 based on active drug treatment based on the use of IABP combined with CRRT (CRRT group) 31 cases or bedside hemodialysis (HD) 21 cases of rescue cardiogenic shock and ARF patients The clinical data were observed in two groups of efficacy and complications. Results: In the CRRT group, 12 patients were successfully rescued with a mortality rate of 61.3%. Three patients were successfully treated in the HD group, with a mortality rate of 90.5% (P <0.05). There was no significant difference between the two groups in the complications of hemorrhage and lower limb ischemia. Conclusion: When IABP rescue cardiogenic shock and ARF, CRRT is the preferred method of dialysis.